Polymorphism in Erlotinib Hydrochloride: New Insights into Relative Stability, Thermal Behavior, and Structural Differences of Forms A and B-Reference-Cited by-同舟云学术

Polymorphism in Erlotinib Hydrochloride: New Insights into Relative Stability, Thermal Behavior, and Structural Differences of Forms A and B

Published:2023-08-29 Issue:10 Volume:23 Page:7374-7384
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

António Catarina T.¹,Évora António O. L.¹,Bernardes Carlos E. S.¹^ORCID,Diogo Hermínio P.²^ORCID,de Araujo Gabriel L. B.³^ORCID,Smith Pamela⁴,Byrn Stephen R.⁵,Fausto Rui⁶^ORCID,Minas da Piedade Manuel E.¹^ORCID

Affiliation:

1. Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal

2. Centro de Química Estrutural, Institute of Molecular Sciences, Complexo Interdisciplinar, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal

3. Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo 05508-900 São Paulo, Brazil

4. Improved Pharma, West Lafayette, Indiana 47906, United States

5. Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana 47906, United States

6. CQC-IMS, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal

Funder

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico

Funda??o para a Ci?ncia e a Tecnologia

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.3c00791

Reference45 articles.

1. Erlotinib Hydrochloride

2. Erlotinib hydrochloride

3. Erlotinib: Small-molecule targeted therapy in the treatmentof non-small-cell lung cancer

4. World Health Organization Model List of Essential Medicines─22nd List. World Health Organization: Geneva, 2021.